Fig. 1From: A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 studyStudy Design of LOGIK1702 Study, A Randomized Phase II Study of S-1 and Cisplatin with Vinorelbine for Completely Resected Stage II/IIIA NSCLCBack to article page